Drug trial aims to shield the brain after a devastating bleed
NCT ID NCT01095731
Summary
This study tested if an existing drug, tiopronin, could help patients recover better after a severe type of brain bleed. Researchers gave the drug or a placebo to 60 patients to see if it could lower levels of a toxic chemical in the brain and improve their neurological function. The goal was to see if reducing this chemical could lead to better long-term outcomes for survivors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
-
University of Florida
Gainesville, Florida, 32611, United States
-
University of Washington
Seattle, Washington, 96104, United States
Conditions
Explore the condition pages connected to this study.